Prospective analysis of 895 patients on a UK Genomics Review Board.
David Allan MooreMarina KushnirGabriel MakHelen WinterTeresa CurielMark VoskoboynikMichele MoschettaNataliya Rozumna-MartynyukKevin BalbiPhilip BennettMartin ForsterAnjana KulkarniDebra HaynesCharles SwantonHendrik-Tobias ArkenauPublished in: ESMO open (2019)
Numerous challenges are faced in implementing a GRB, including the identification of potential germline variants, the interpretation of variants of uncertain significance and consideration of the technical limitations of pathology material when interpreting results. These challenges are likely to be encountered with increasing frequency in routine practice. This GRB experience provides a model for the multidisciplinary review of molecular profiling data and for the linking of molecular analysis to clinical trial networks.